[ad_1] Opill Oral Contraception Source: Perrigo The Food and Drug Administration on Tuesday raised substantial concerns about a drugmaker’s application for sales of a birth control pill without a prescription. A committee of independent experts who advise the FDA is meeting Tuesday and Wednesday to make a recommendation on whether data submitted by HRA Pharma…
[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Most women should get screened for breast cancer every other year starting at age 40, a decade earlier than previously recommended, according to draft guidelines issued Tuesday by a government-backed panel…
[ad_1] The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters A Delaware federal court jury on Tuesday cleared Gilead Sciences of civil claims by the U.S. government that the company violated patents held by the Centers for Disease Control and Prevention for an HIV prevention…
[ad_1] A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax jumped more than 50% on Tuesday after the company unveiled promising new vaccine data and…
[ad_1] Director of the Centers for Disease Control Rochelle Walensky departs after testifying before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act at the Dirksen Senate Office Building on Thursday, May 4, 2023 in Washington, DC. Kent Nishimura | Los Angeles Times | Getty Images CDC Director Dr. Rochelle…
[ad_1] People walk by a Covid-19 testing site at Times Square on May 12, 2022 in New York City. Liao Pan | China News Service | Getty Images The Centers for Disease Control and Prevention will have less data to track the spread of Covid-19 and new variants in the U.S. after the public health…
[ad_1] Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), speaks during a news conference in Geneva, Switzerland, December 20, 2021. Denis Balibouse | Reuters The spread of Covid-19 is no longer a global public health emergency, the World Health Organization declared Friday. “For more than a year, the pandemic has been on a…
[ad_1] Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out…
[ad_1] Johnson & Johnson ‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue…
[ad_1] Shares of Johnson & Johnson‘s consumer-health spinoff Kenvue jumped 20% in afternoon trading Thursday after its market debut on the New York Stock Exchange, making it the biggest U.S. IPO in more than a year. The new company opened at $25.53 per share after originally pricing its initial public offering at $22 Wednesday night,…
